Mylan announced the launch of Linezolid Tablets, the generic version of Pfizer‘s Zyvox Tablets.

Zyvox is an oxazolidinone antibiotic indicated to treat children and adults with susceptible vancomycin-resistant E. faecium (VREF) infections, nosocomial and community-acquired pneumonia, complicated skin and skin structure infections (including diabetic foot infections) without osteomyelitis, uncomplicated skin and skin structure infections.

RELATED: Cefotan Inj Regains Approval After Discontinuation

Linezolid works by binding to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process. 

Linezolid Tablets are available in a 600mg strength.

For more information call (800) RX-MYLAN or visit Mylan.com.